Fluorescein angiographic characteristic in predominantly classic and occult types of neovascular age-related macular degeneration treated with ranibizumab

BACKGROUND AND PURPOSE: Randomised-controlled clinical trials (the ANCHOR and MARINA) examined the intravitreal anti-vascular endothelial growth factor (anti-VEGF) efficacy for eyes having fluorescein angiographic classic and occult (OCC) neovascular lesions. No significant difference in the treatme...

Descripción completa

Detalles Bibliográficos
Autores principales: Çavdarlı, Cemal, Çomçalı, Sebile, Topcu Yılmaz, Pınar, Alp, Mehmet Numan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053751/
https://www.ncbi.nlm.nih.gov/pubmed/33948533
http://dx.doi.org/10.1177/25158414211005305

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053751/
https://www.ncbi.nlm.nih.gov/pubmed/33948533
http://dx.doi.org/10.1177/25158414211005305

Ejemplares similares